{
    "relation": [
        [
            "",
            "Number of Participants Analyzed [units: participants]",
            "Number of Participants Taking Concomitant Therapy [units: participants]",
            "ABC, FTC/TDF (Month 12)",
            "ABC, FTC/TDF (Baseline, Month 12)",
            "ABC/LAM (Month 12)",
            "ABC/LAM (Baseline, Month 12)",
            "ABC/LAM, DRV, RAL (Month 12)",
            "ABC/LAM, DRV, RAL (Baseline, Month 12)",
            "ABC/LAM, RAL (Month 12)",
            "ABC/LAM, RAL (Baseline, Month 12)",
            "ABC/LAM, RAL, TDF (Month 12)",
            "ABC/LAM, RAL, TDF (Baseline, Month 12)",
            "ATV (Month 12)",
            "ATV (Baseline, Month 12)",
            "ATV, FTC/TDF (Month 12)",
            "ATV, FTC/TDF (Baseline, Month 12)",
            "ATV, FTC/TDF, RTV (Month 12)",
            "ATV, FTC/TDF, RTV (Baseline, Month 12)",
            "ATV, LAM, RAL, RTV (Month 12)",
            "ATV, LAM, RAL, RTV (Baseline, Month 12)",
            "ATV, RAL (Month 12)",
            "ATV, RAL (Baseline, Month 12)",
            "ATV, RAL, RTV (Month 12)",
            "ATV, RAL, RTV (Baseline, Month 12)",
            "ATV, RTV (Month 12)",
            "ATV, RTV (Baseline, Month 12)",
            "DRV, FTC/TDF (Month 12)",
            "DRV, FTC/TDF (Baseline, Month 12)",
            "DRV, FTC/TDF, ETR (Month 12)",
            "DRV, FTC/TDF, ETR (Baseline, Month 12)",
            "DRV, FTC/TDF, RTV (Month 12)",
            "DRV, FTC/TDF, RTV (Baseline, Month 12)",
            "DRV, ETV, ETR, RTV (Month 12)",
            "DRV, ETV, ETR, RTV (Baseline, Month 12)",
            "DRV, LAM, RAL (Month 12)",
            "DRV, LAM, RAL (Baseline, Month 12)",
            "DRV, LAM, RAL, RTV (Month 12)",
            "DRV, LAM, RAL, RTV (Baseline, Month 12)",
            "DRV, LAM, TDF (Month 12)",
            "DRV, LAM, TDF (Baseline, Month 12)",
            "DRV, NVP, RAL, RTV (Month 12)",
            "DRV, NVP, RAL, RTV (Baseline, Month 12)",
            "DRV, RAL, RTV (Month 12)",
            "DRV, RAL, RTV (Baseline, Month 12)",
            "DRV, RTV (Month 12)",
            "DRV, RTV (Baseline, Month 12)",
            "DRV, RTV, TZV (Month 12)",
            "DRV, RTV, TZV (Baseline, Month 12)",
            "FTC/TDF (Month 12)",
            "FTC/TDF (Baseline, Month 12)",
            "FTC/TDF, Kaletra (Month 12)",
            "FTC/TDF, Kaletra (Baseline, Month 12)",
            "FTC/TDF, Kaletra, RAL (Month 12)",
            "FTC/TDF, Kaletra, RAL (Baseline, Month 12)",
            "FTC/TDF, Kaletra, SQV (Month 12)",
            "FTC/TDF, Kaletra, SQV (Baseline, Month 12)",
            "FTC/TDF, RAL (Month 12)",
            "FTC/TDF, RAL (Baseline, Month 12)",
            "FTC/TDF, RAL, SQV (Month 12)",
            "FTC/TDF, RAL, SQV (Baseline, Month 12)",
            "ETR, RAL, RTV (Month 12)",
            "ETR, RAL, RTV (Baseline, Month 12)",
            "Kaletra (Month 12)",
            "Kaletra (Baseline, Month 12)",
            "LAM, RAL, TDF, ZDV (Month 12)",
            "LAM, RAL, TDF, ZDV (Baseline, Month 12)",
            "RAL (Month 12)",
            "RAL (Baseline, Month 12)",
            "RAL, TDF (Month 12)",
            "RAL, TDF (Baseline, Month 12)",
            "RAL, ZDV W/LAM (Month 12)",
            "RAL, ZDV W/LAM (Baseline, Month 12)",
            "TDF, TZV (Month 12)",
            "TDF, TZV (Baseline, Month 12)",
            "TDF, ZDV (Month 12)",
            "TDF, ZDV (Baseline, Month 12)"
        ],
        [
            "Maraviroc",
            "79",
            "",
            "1",
            "1",
            "2",
            "2",
            "1",
            "0",
            "2",
            "2",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "0",
            "2",
            "2",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "6",
            "5",
            "1",
            "0",
            "1",
            "0",
            "1",
            "0",
            "1",
            "1",
            "1",
            "1",
            "4",
            "4",
            "2",
            "2",
            "1",
            "1",
            "13",
            "11",
            "2",
            "1",
            "3",
            "3",
            "1",
            "1",
            "5",
            "4",
            "1",
            "1",
            "1",
            "0",
            "2",
            "2",
            "1",
            "0",
            "2",
            "2",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1"
        ]
    ],
    "pageTitle": "Non-Interventional Study Of Celsentri\u00ae In Treatment Experienced Patients With CCR5-Tropic HIV-Infection - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00850395?sect=Xj0156&view=results",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988312.76/warc/CC-MAIN-20150728002308-00083-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 855908722,
    "recordOffset": 855892328,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Participant Flow: \u00a0 Overall Study Participants who were prescribed maraviroc tablets orally in accordance with Summary of Product Characteristics (SmPC) were observed for a period of up to 12 months or early discontinuation. Maraviroc Description \u00a0 Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details No text entered. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Drug: maraviroc Intervention: HIV-1 Condition:",
    "textAfterTable": "11.\u00a0 Secondary: \u00a0 Number of Participants With Human Immunodeficiency Virus (HIV) Response \u00a0 [ Time Frame: Month 12 ] \u00a0 Show Outcome Measure 11 12.\u00a0 Secondary: \u00a0 Physician's Assessment of Efficacy \u00a0 [ Time Frame: Month 12 ] \u00a0 Show Outcome Measure 12 13.\u00a0 Secondary: \u00a0 Number of Participants Taking Concomitant Therapy \u00a0 [ Time Frame: Baseline, Month 12 ] \u00a0 Hide Outcome Measure 13 Measure\u00a0Type Secondary Measure\u00a0Title Number of Participants Taking Concomitant Therapy Measure\u00a0Description Participants taking HIV/AIDS concomitant medication at Month 12, at Baseline and Month 12 were reported. It included Emtricitabine/tenofovir disoproxil fumarate(FTC/TDF),Raltegravir(RAL), Ritonavir (RTV), Darunavir(DRV), Kaletra, Atazanavir sulfate(ATV), Abacavir sulfate/lamivudine(ABC/LAM), Tenofovir disoproxil fumarate(TDF), Etravirine(ETR), Lamivudine (LAM),",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}